Founder and Chief Investment Officer, Blue Orca Capital
Soren Aandahl is the former director of research of Glaucus Research and the Chief Investment Officer of Glaucus Investments. In May 2018, Mr. Aandahl launched a new investment firm, Blue Orca Capital, to focus on global short activist investments.
Under Mr. Aandahl, Glaucus was ranked the #1 activist short seller in the world in 2016, measured by performance and overall market impact. From 2011 to 2018, Glaucus shared 28 short investment reports alerting investors to publicly available evidence indicating that a company had materially misrepresented its financial performance, had misappropriated money raised from investors or was otherwise overvalued. In multiple instances, management was charged with securities fraud and the subject companies were delisted. Glaucus’ most notable activist short campaign in 2017 was Australia’s Quintis, which collapsed into administration after Glaucus alerted the market that Quintis had vastly overstated the value of its biological assets and concealed the termination of key customer contracts.
Mr. Aandahl is regularly featured in the Financial Times, New York Times, South China Morning Post, Bloomberg and the Wall Street Journal on various topics including corporate governance, financial fraud and short selling. Prior to Glaucus, Mr. Aandahl was a securities and M&A attorney at the global law firm of Kirkland & Ellis in New York. Mr. Aandahl clerked for the Honorable Judge Algenon L. Marbley of the Southern District Court of Ohio, and in law school interned at the United States Attorney’s Office where he worked with lawyers on the Enron task force. Mr. Aandahl has a JD from Harvard Law School and a BA from the University of Chicago, from which he graduated Phi Beta Kappa.